Ryan Gerbrandt's most recent trade in Anterix Inc was a trade of 67,774 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 67,774 | 67,774 | - | - | Stock Option (Right to Buy) | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 61,462 | 61,462 | - | - | Stock Option (Right to Buy) | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.51 per share. | 12 Jul 2024 | 1,479 | 48,091 (0%) | 0% | 41.5 | 61,393 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.52 per share. | 17 May 2024 | 1,391 | 49,570 (0%) | 0% | 33.5 | 46,626 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.72 per share. | 15 May 2024 | 2,867 | 50,961 (0%) | 0% | 32.7 | 93,808 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.76 per share. | 15 Feb 2024 | 2,456 | 53,828 (0%) | 0% | 37.8 | 92,739 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 10,087 | 56,284 (0%) | 0% | 0 | Common Stock | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.11 per share. | 18 May 2023 | 4,282 | 46,197 (0%) | 0% | 31.1 | 133,213 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.73 per share. | 15 Feb 2023 | 2,485 | 50,479 (0%) | 0% | 32.7 | 81,334 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 27 May 2022 | 2,898 | 54,638 (0%) | 0% | 42.5 | 123,078 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 25,511 | 25,511 | - | - | Stock Option (Right to Buy) | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 12,655 | 57,536 (0%) | 0% | 0 | Common Stock | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 54.10 per share. | 17 Feb 2022 | 1,674 | 52,964 (0%) | 0% | 54.1 | 90,563 | Common Stock |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 26,087 | 44,881 (0%) | 0% | 0 | Common Stock | |
Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 17 Feb 2021 | 2,018 | 18,794 (0%) | 0% | 42 | 84,756 | Common Stock |